# Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314)

> **NCT00157963** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 174 (actual)

## Conditions studied

- Essential Hypertension

## Interventions

- **DRUG:** MK0954A; hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 12 weeks

## Key facts

- **NCT ID:** NCT00157963
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02-05
- **Primary completion:** 2006-02-08
- **Final completion:** 2006-02-08
- **Target enrollment:** 174 (ACTUAL)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00157963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00157963, "Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00157963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*